254 related articles for article (PubMed ID: 21321113)
1. Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.
Heller C; Weisser T; Mueller-Schickert A; Rufer E; Hoh A; Leonhardt RM; Knittler MR
J Biol Chem; 2011 Apr; 286(13):10983-97. PubMed ID: 21321113
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
Zhou F; Chen J; Zhao KN
J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
4. HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter.
Li H; Ou X; Xiong J; Wang T
Biochem Biophys Res Commun; 2006 Nov; 349(4):1315-21. PubMed ID: 16979588
[TBL] [Abstract][Full Text] [Related]
5. RNA interference of human papillomavirus type 16 E7 increases HLA class I antigen expression in HaCaT-E7 cells.
Deng XM; Li W; Zhang X; Wang CX; Dong ZG; Zhang X; Zheng GX; Zhang XH; Zheng N; Wang LL; Du LT; Wang S
Int J Gynecol Cancer; 2011 Jan; 21(1):28-34. PubMed ID: 21330828
[TBL] [Abstract][Full Text] [Related]
6. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
Ajiro M; Zheng ZM
mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
[TBL] [Abstract][Full Text] [Related]
7. A novel recombinant protein vaccine containing the different E7 proteins of the HPV16, 18, 6, 11 E7 linked to the HIV-1 Tat (47-57) improve cytotoxic immune responses.
Mousavi T; Valadan R; Rafiei A; Abbasi A; Haghshenas MR
Biotechnol Lett; 2021 Sep; 43(9):1933-1944. PubMed ID: 34313864
[TBL] [Abstract][Full Text] [Related]
8. ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity.
Mikuličić S; Shamun M; Massenberg A; Franke AL; Freitag K; Döring T; Strunk J; Tenzer S; Lang T; Florin L
Front Immunol; 2024; 15():1335302. PubMed ID: 38370412
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
10. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
12. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE
Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295
[TBL] [Abstract][Full Text] [Related]
13. Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen Presentation.
Abdelaziz MO; Ossmann S; Kaufmann AM; Leitner J; Steinberger P; Willimsky G; Raftery MJ; Schönrich G
Front Immunol; 2019; 10():1776. PubMed ID: 31417555
[TBL] [Abstract][Full Text] [Related]
14. Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
Hu R; Dong Z; Zhang K; Pan G; Li C; Cui H
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204370
[TBL] [Abstract][Full Text] [Related]
15. High-Risk Human Papillomavirus E7 Alters Host DNA Methylome and Represses HLA-E Expression in Human Keratinocytes.
Cicchini L; Blumhagen RZ; Westrich JA; Myers ME; Warren CJ; Siska C; Raben D; Kechris KJ; Pyeon D
Sci Rep; 2017 Jun; 7(1):3633. PubMed ID: 28623356
[TBL] [Abstract][Full Text] [Related]
16. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
17. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.
Baldwin A; Huh KW; Münger K
J Virol; 2006 Jul; 80(13):6669-77. PubMed ID: 16775354
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
[TBL] [Abstract][Full Text] [Related]
20. A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization.
Jönsson J; Wang L; Kajitani N; Schwartz S
Nucleic Acids Res; 2024 Jan; 52(1):316-336. PubMed ID: 37994701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
